175 related articles for article (PubMed ID: 27888801)
1. Common profiles of Notch signaling differentiate disease-free survival in luminal type A and triple negative breast cancer.
Orzechowska M; Jędroszka D; Bednarek AK
Oncotarget; 2017 Jan; 8(4):6013-6032. PubMed ID: 27888801
[TBL] [Abstract][Full Text] [Related]
2. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.
Ortiz-Martínez F; Gutiérrez-Aviñó FJ; Sanmartín E; Pomares-Navarro E; Villalba-Riquelme C; García-Martínez A; Lerma E; Peiró G
Exp Mol Pathol; 2016 Jun; 100(3):460-8. PubMed ID: 27118257
[TBL] [Abstract][Full Text] [Related]
3. Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma.
Grilli G; Hermida-Prado F; Álvarez-Fernández M; Allonca E; Álvarez-González M; Astudillo A; Moreno-Bueno G; Cano A; García-Pedrero JM; Rodrigo JP
Oral Oncol; 2020 Nov; 110():105003. PubMed ID: 32932170
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of epithelial–mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer.
Pomp V; Leo C; Mauracher A; Korol D; Guo W; Varga Z
Breast Cancer Res Treat; 2015 Nov; 154(1):45-55. PubMed ID: 26467042
[TBL] [Abstract][Full Text] [Related]
5. NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling.
Zhang J; Shao X; Sun H; Liu K; Ding Z; Chen J; Fang L; Su W; Hong Y; Li H; Li H
Oncotarget; 2016 Sep; 7(38):61036-61053. PubMed ID: 27506933
[TBL] [Abstract][Full Text] [Related]
6. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition.
Wang H; Sang M; Geng C; Liu F; Gu L; Shan B
Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233
[TBL] [Abstract][Full Text] [Related]
7. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
[TBL] [Abstract][Full Text] [Related]
8. HES1 promotes metastasis and predicts poor survival in patients with colorectal cancer.
Yuan R; Ke J; Sun L; He Z; Zou Y; He X; Chen Y; Wu X; Cai Z; Wang L; Wang J; Fan X; Wu X; Lan P
Clin Exp Metastasis; 2015 Feb; 32(2):169-79. PubMed ID: 25636905
[TBL] [Abstract][Full Text] [Related]
9. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
Zhang S; Chung WC; Xu K
Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of Notch receptors in triple negative breast cancer.
Shah H; Mistry M; Patel N; Vora H
Breast Dis; 2023; 42(1):85-100. PubMed ID: 36970890
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.
Cohen B; Shimizu M; Izrailit J; Ng NF; Buchman Y; Pan JG; Dering J; Reedijk M
Breast Cancer Res Treat; 2010 Aug; 123(1):113-24. PubMed ID: 19915977
[TBL] [Abstract][Full Text] [Related]
12. Age- and Stage-Dependent Prostate Cancer Aggressiveness Associated with Differential Notch Signaling.
Orzechowska MJ; Anusewicz D; Bednarek AK
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613607
[TBL] [Abstract][Full Text] [Related]
13. The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC).
Narrandes S; Huang S; Murphy L; Xu W
BMC Cancer; 2018 Jan; 18(1):22. PubMed ID: 29301506
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic Notch Promotes Long-Range Regulatory Interactions within Hyperconnected 3D Cliques.
Petrovic J; Zhou Y; Fasolino M; Goldman N; Schwartz GW; Mumbach MR; Nguyen SC; Rome KS; Sela Y; Zapataro Z; Blacklow SC; Kruhlak MJ; Shi J; Aster JC; Joyce EF; Little SC; Vahedi G; Pear WS; Faryabi RB
Mol Cell; 2019 Mar; 73(6):1174-1190.e12. PubMed ID: 30745086
[TBL] [Abstract][Full Text] [Related]
15. Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma.
Bennani-Baiti IM; Aryee DN; Ban J; Machado I; Kauer M; Mühlbacher K; Amann G; Llombart-Bosch A; Kovar H
J Pathol; 2011 Nov; 225(3):353-63. PubMed ID: 21984123
[TBL] [Abstract][Full Text] [Related]
16. Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1.
Li Y; Zhang Y; Liu X; Wang M; Wang P; Yang J; Zhang S
Int J Oncol; 2018 Jun; 52(6):2119-2129. PubMed ID: 29620169
[TBL] [Abstract][Full Text] [Related]
17. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer.
Tsai YF; Tseng LM; Hsu CY; Yang MH; Chiu JH; Shyr YM
PLoS One; 2017; 12(6):e0178173. PubMed ID: 28604807
[TBL] [Abstract][Full Text] [Related]
19. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
20. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS
Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]